EUGIA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and when can generic versions of EUGIA PHARMA drugs launch?
EUGIA PHARMA has one hundred and seventy approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and fifty-two supplementary protection certificates in eighteen countries.
Summary for EUGIA PHARMA
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 144 |
| Ingredients: | 136 |
| NDAs: | 170 |
| Patent Litigation for EUGIA PHARMA: | See patent lawsuits for EUGIA PHARMA |
Drugs and US Patents for EUGIA PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 205520-001 | Jul 23, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma Speclts | ARGATROBAN IN SODIUM CHLORIDE | argatroban | SOLUTION;INTRAVENOUS | 209552-001 | Nov 27, 2018 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eugia Pharma | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 207667-003 | Dec 15, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eugia Pharma | BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 203895-002 | Nov 5, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EUGIA PHARMA Drugs
Supplementary Protection Certificates for EUGIA PHARMA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2603514 | 19C1021 | France | ⤷ Sign Up | PRODUCT NAME: COMBINAISON DE VABORBACTAME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, ET DE MEROPENEME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, EN PARTICULIER DE MEROPENEME TRIHYDRATE; REGISTRATION NO/DATE: EU/1/18/1334 20181122 |
| 0186405 | SPC/GB00/021 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316 |
| 2673237 | 1990016-6 | Sweden | ⤷ Sign Up | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326 |
| 1411918 | CA 2012 00026 | Denmark | ⤷ Sign Up | PRODUCT NAME: PLERIXAFOR I ALLE FORMER SOM BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/01/09/537/001 20090804 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
